Impact of Depression on Thermoregulation
Recruiting now
Conditions studied: Depression, Selective Serotonin Reuptake Inhibitor
In brief
The purpose of this study is to determine if, compared to non-depressed adults, differences exist in skin blood flow and sweating responses to passive heat stress in adults with clinically diagnosed depression, those with depression who are prescribed and taking SSRIs and those with depression who are prescribed and taking SNRIs.
Key facts
- Study ID
- NCT06805851
- Run by
- Penn State University
- People needed
- 64
- Starts
- 2025-03-01
- Expected to finish
- 2027-01-30
- Last updated by the study team
- 2026-02-03
Who can join
Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Non-depressed adults aged 18-40 years;
- OR adults aged 18-40 years with clinically diagnosed major depressive disorder according to DSM-V criteria not currently receiving antidepressant treatment;
- OR adults aged 18-40 years with clinically diagnosed major depressive disorder with at least 2 weeks of treatment with a selective serotonin reuptake inhibitor;
- OR aged 18-40 years adults with clinically diagnosed major depressive disorder with at least 2 weeks of treatment with a serotonin norepinephrine reuptake inhibitor;
- All participants will be asymptomatic and no signs/symptoms of disease according to the American College of Sports Medicine 10th edition Guidelines for Exercise Testing and Prescription (chest pain or pressure, dizziness, joint pain, and signs of cardiovascular disease);
- Systolic blood pressure 140 mmHg and diastolic pressure 90 mmHg at screening;
- Non-diabetic
- Not taking any other medications that might affect the physiological variables of interest (beta blockers, tricyclic antidepressants, antipyretics, diuretics, etc.);;
- Between the 20th and 80th percentiles for sex- and age-appropriate VO2max according to the American College of Sports Medicine 10th edition Guidelines for Exercise Testing and Prescription;
- English proficiency;
- Capable of providing informed consent.
You may not qualify if…
- BMI > 35
- Are pregnant or planning to become pregnant in the next 12 months;
- Concurrently participate in another study involving physical activity or weight loss;
- Plan to have surgery or relocate outside the area within the next year;
- Medications that could alter cardiovascular or thermoregulatory responses to exercise (beta blockers, antipyretics, tricyclic antidepressants, diuretics, etc.);
- Allergy to latex or adhesive;
- Tobacco use;
- Illegal/recreational drug use;
- Exertional chest pain or musculoskeletal pain;
- Contraindications to a maximal exercise test or an indication for early termination of the exercise test according to the American College of Sports Medicine 10th edition Guidelines for Exercise Testing and Prescription;
- Abnormal resting or exercise electrocardiogram (ECG);
- Any bleeding disorders, gastric ulcers, allergies to NSAIDS, asthma, kidney/liver disorders, and taking any other anticoagulants;
- History of Crohn's disease, diverticulitis, or similar gastrointestinal disease;
- Co-morbid psychiatric disorders (psychosis, schizophrenia, bipolar disorder, panic disorder, obsessive compulsive disorder, etc.);
- Active suicidal ideation (moderate or high suicidality);
- Use of psychoactive or psychopharmacological drugs other than SSRI and SNRIs within one year of participating.
Where it is running
- Noll Laboratory — University Park, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.